Wooten Kiley M, Arnall Justin R, Bowser Kiarra M, J Pennell Laurie, Wade-Davis Jazmin N, Olin Jacqueline L, Taylor Margaret, Moore Donald C
Wingate University School of Pharmacy, Wingate, NC, USA.
Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
J Oncol Pharm Pract. 2021 Mar 27:10781552211004700. doi: 10.1177/10781552211004700.
Professional conferences are where research findings are initially presented. Studies suggest many research ideas presented at conferences are never published. Previous studies have demonstrated that the full publication rate of abstracts presented at pharmacy meetings is approximately 20%. The objective of this study was to determine the full publication rate of hematology/oncology abstracts presented at major pharmacy organization annual meetings.
A systematic search of PubMed and Google Scholar was performed. Publication status was evaluated for hematology/oncology abstracts presented at annual meetings for the following organizations: American College of Clinical Pharmacy Annual Meeting, American Society of Health-System Pharmacists Midyear Clinical Meeting, Hematology/Oncology Pharmacy Association Annual Meeting, and International Society of Oncology Pharmacy Practitioners Annual Meeting. Data collected included the meeting of abstract presentation, number of authors, abstract study type, country of origin, journal of publication, and type of publication. Abstracts presented as trainee research were excluded.
Of 451 oncology abstracts evaluated, the most common topic categories included pharmacotherapy (n = 244; 54.1%), clinical pharmacy practice (n = 84; 18.6%), and operational/compounding (n = 69; 15.3%). The overall publication rate was 17.5% (n = 79). Abstracts were published as full manuscripts over a spread of 48 different journals. Factors associated with full publication included abstracts with more than 5 authors (OR 3.86, 95% CI 2.32-6.43; p < 0.0001) and abstracts presented at oncology-focused pharmacy meetings (OR 2.92, 95% CI 1.49-5.72; p = 0.0018).
This study showed an overall publication rate of 17.5% for abstracts presented at pharmacy meetings, consistent with prior studies.
专业会议是研究成果首次展示的地方。研究表明，在会议上展示的许多研究想法从未发表。先前的研究表明，在药学会议上展示的摘要的完整发表率约为20%。本研究的目的是确定在主要药学组织年会上展示的血液学/肿瘤学摘要的完整发表率。
对PubMed和谷歌学术进行了系统检索。对以下组织年会上展示的血液学/肿瘤学摘要的发表状态进行了评估：美国临床药师学会年会、美国卫生系统药师协会年中临床会议、血液学/肿瘤药学协会年会和国际肿瘤药学从业者协会年会。收集的数据包括摘要展示会议、作者数量、摘要研究类型、原产国、发表期刊和发表类型。作为实习研究展示的摘要被排除。
在评估的451篇肿瘤学摘要中，最常见的主题类别包括药物治疗（n = 244；54.1%）、临床药学实践（n = 84；18.6%）和操作/配药（n = 69；15.3%）。总体发表率为17.5%（n = 79）。摘要以完整手稿形式发表在48种不同的期刊上。与完整发表相关的因素包括作者超过5人的摘要（OR 3.86，95%CI 2.32 - 6.43；p < 0.0001）以及在专注于肿瘤学的药学会议上展示的摘要（OR 2.92，95%CI 1.49 - 5.72；p = 0.0018）。
本研究表明，药学会议上展示的摘要总体发表率为17.5%，与先前的研究一致。
